Last Updated: May 2, 2026

amcinonide - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for amcinonide and what is the scope of patent protection?

Amcinonide is the generic ingredient in two branded drugs marketed by Genus Lifesciences, Taro Pharm Inds, Astellas, Solubiomix, and Genus, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

Summary for amcinonide
US Patents:0
Tradenames:2
Applicants:5
NDAs:8

US Patents and Regulatory Information for amcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus Lifesciences AMCINONIDE amcinonide CREAM;TOPICAL 076065-001 May 15, 2003 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Taro Pharm Inds AMCINONIDE amcinonide CREAM;TOPICAL 076229-001 May 31, 2002 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Solubiomix AMCINONIDE amcinonide LOTION;TOPICAL 076329-001 Nov 6, 2002 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Astellas CYCLOCORT amcinonide LOTION;TOPICAL 019729-001 Jun 13, 1988 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for amcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-002 Approved Prior to Jan 1, 1982 ⤷  Start Trial ⤷  Start Trial
Astellas CYCLOCORT amcinonide OINTMENT;TOPICAL 018498-001 Approved Prior to Jan 1, 1982 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.